Specify a stock or a cryptocurrency in the search bar to get a summary
Oxford Biodynamics PLC
OXBOFOxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom. Address: 3140 Rowan Place, Oxford, United Kingdom, OX4 2WB
Analytics
WallStreet Target Price
13 326.23 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures OXBOF
Dividend Analytics OXBOF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OXBOF
Stock Valuation OXBOF
Financials OXBOF
Results | 2019 | Dynamics |